Daniele Santini | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma	ANTI-CANCER DRUGS	2018
Breakthrough cancer pain (BTcP) management: a review of international and national guidelines	BMJ SUPPORTIVE & PALLIATIVE CARE	2018
Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram	ONCOLOGY	2018
Association among metabolic syndrome, inflammation, and survival in prostate cancer	UROLOGIC ONCOLOGY	2018
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma	ANTICANCER RESEARCH	2018
Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy	PLOS ONE	2018
The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A "hypothesis-generator' study from clinical practice	ONCOLOGY LETTERS	2018
Optimising the use of cetuximab in the continuum of care for patients with metastatic colorectal cancer	ESMO OPEN	2018
Is It Possible to Improve Prognostic Classification in Patients Affected by Metastatic Renal Cell Carcinoma With an Intermediate or Poor Prognosis?	CLINICAL GENITOURINARY CANCER	2018
Bone metastases in biliary cancers: A multicenter retrospective survey	JOURNAL OF BONE ONCOLOGY	2018
Nutrition in patients with cancer: a new area for medical oncologists? A practising oncologist's interdisciplinary position paper	ESMO OPEN	2018
Long-term Response to First-line Pazopanib Therapy in mRCC Patients: A Multicenter Italian Experience	ANTICANCER RESEARCH	2018
Corrigendum: Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter? (vol 13, pg 2791, 2017)	FUTURE ONCOLOGY	2018
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin	ONCOLOGY	2018
Radiotherapy and vascular endothelial growth factor receptor-tyrosine kinase inhibitors in renal cancer	CHEMOTHERAPY	2018
Molecular profiling of pancreatic neuroendocrine tumors (pNETS) and the clinical potential	EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY	2018
T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer	THE BREAST	2018
Molecular profiling of pancreatic neuroendocrine tumors (pNETS) and the clinical potential	EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY	2018
Management of metastatic castration-resistant prostate cancer: A focus on radium-223: Opinions and suggestions from an expert multidisciplinary panel	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY	2017
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience	ONCOTARGET	2017